Emergent BioSolutions is a global life sciences company that develops and manufactures medical countermeasures to prepare and protect civilian and military populations against accidental, intentional, and naturally occurring public health threats. Our products target biological and chemical threats, as well as emerging infectious diseases.
For 20 years, Emergent has focused on a singular mission—to protect and enhance life. Emergent has extensive experience in working in partnership with governments worldwide to develop, manufacture, and deliver vaccines, therapeutics, and devices against CBRN threats. Emergent celebrates the talent, drive, and innovation that have shaped its growth and continued vision to improve the quality of life for millions of individuals around the world.
Through its work, Emergent envisions protecting and enhancing 50 million lives with its products by 2025.